Earnings History Data for Alkermes plc (ALKS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Alkermes plc

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-10-2021 PM 7:00 AM ET
(Oct 27)
ALKS Alkermes plc 4,980 N/A -0.05 0.12 Alkermes EPS beats by $0.04, misses on revenue
[10/27/2021 7:28 AM]
28.65 -2.86 
(-9.08%)
28.65 0.0 
(0.00%)
15.35 - 33.00 2,579,024 1,070,000 16,451
28-07-2021 PM 7:00 AM ET
(Jul 28)
ALKS Alkermes plc 3,910 0.13 -0.02 -0.08 Alkermes EPS beats by $0.18, beats on revenue
[7/28/2021 7:09 AM]
25.77 1.63 
(6.75%)
25.77 0.0 
(0.00%)
15.35 - 25.91 1,605,798 1,310,000 456
28-04-2021 PM 7:00 AM ET
(Apr 28)
ALKS Alkermes plc 3,580 0.01 -0.21 -0.09 Alkermes EPS beats by $0.12, beats on revenue
[4/28/2021 7:08 AM]
21.79 -0.71 
(-3.16%)
22.00 -0.50 
(-2.22%)
13.03 - 23.92 1,497,795 1,610,000 1,466
11-02-2021 PM 7:00 AM ET
(Feb 11)
ALKS Alkermes plc 3,670 -0.05 -0.04 0.69 Alkermes EPS beats by $0.03, beats on revenue
[2/11/2021 7:07 AM]
20.10 -2.84 
(-12.36%)
22.71 -0.22 
(-0.96%)
11.98 - 23.92 3,344,403 1,295,882 1,880
29-10-2020 PM 7:00 AM ET
(Oct 29)
ALKS Alkermes plc 2,530 0.12 -0.14 -0.22 Alkermes EPS beats by $0.26, beats on revenue
[10/29/2020 7:06 AM]
16.28 0.89 
(5.78%)
16.10 0.71 
(4.61%)
11.98 - 21.88 1,897,850 1,054,901 4,409
29-07-2020 PM 7:00 AM ET
(Jul 29)
ALKS Alkermes plc 3,280 -0.08 -0.13 -0.06 Alkermes EPS beats by $0.06, beats on revenue
[7/29/2020 7:02 AM]
19.84 -0.34 
(-1.71%)
20.20 0.02 
(0.10%)
11.98 - 23.50 1,195,754 1,610,133 306